In various preclinical models of colorectal cancer (CRC), IGF2BP2 was identified as the most prevalent IGF2BP family member in both primary and metastatic CRC, showing a correlation with tumor stage in patient samples and promoting tumor growth [53]. Here, IGF2BP2 is linked to neoplasm.